Literature DB >> 17153514

Hepatitis C knowledge among staff in U.S. drug treatment programs.

Shiela M Strauss1, Janetta M Astone-Twerell, Corrine Munoz-Plaza, Don C Des Jarlais, Marya Gwadz, Holly Hagan, Andrew Osborne, Andrew Rosenblum.   

Abstract

Staff in drug treatment programs are in an optimal position to support the hepatitis C related needs of their patients. To do so effectively, however, staff need to have accurate information about the hepatitis C virus (HCV). This article examines the HCV knowledge of staff (N= 104) in two drug-free and two methadone maintenance treatment programs (MMTPs) in the New York metropolitan area. Five of 20 items on an HCV Knowledge Assessment were not answered correctly by the majority of the participating staff, and total scores on the Assessment averaged 70%, 71%, and 45% among the medically credentialed staff, non-medically credentialed staff in the MMTPs, and non-medically credentialed staff in the drug-free programs, respectively. The majority of those in the latter group had never participated in a training specifically devoted to HCV. Results suggest the need for effective HCV-related training for all staff in drug treatment programs.

Entities:  

Mesh:

Year:  2006        PMID: 17153514     DOI: 10.2190/3EMQ-N350-W4XN-WT1X

Source DB:  PubMed          Journal:  J Drug Educ        ISSN: 0047-2379


  11 in total

1.  Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment.

Authors:  Andrew H Talal; Rositsa B Dimova; Randy Seewald; Raymond H Peterson; Marija Zeremski; David C Perlman; Don C Des Jarlais
Journal:  J Subst Abuse Treat       Date:  2012-03-08

2.  Hepatitis C knowledge and alcohol consumption among patients receiving methadone maintenance treatment in Shanghai, China.

Authors:  Jiang Du; Zhen Wang; Bin Xie; Min Zhao
Journal:  Am J Drug Alcohol Abuse       Date:  2012-01-13       Impact factor: 3.829

3.  Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study.

Authors:  Jemima A Frimpong; Thomas D'Aunno; Lan Jiang
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

Review 4.  Barriers to hepatitis C treatment.

Authors:  Christopher E McGowan; Michael W Fried
Journal:  Liver Int       Date:  2012-02       Impact factor: 5.828

5.  Enhancing Drug Treatment Program Staff's Self-Efficacy to Support Patients' HCV Needs.

Authors:  Shiela M Strauss; Corrine Munoz-Plaza; Mary T Rosedale; David M Rindskopf; Joseph Lunievicz
Journal:  J Soc Work Pract Addict       Date:  2011-01-01

6.  Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China.

Authors:  Y Hser; J Du; J Li; M Zhao; Y J Chang; C Y Peng; E Evans
Journal:  J Public Health (Oxf)       Date:  2011-12-02       Impact factor: 2.341

7.  Development of a Measure of Hepatitis C-alcohol Knowledge.

Authors:  Rae Jean Proeschold-Bell; Jia Yao; Sisira Gorthala; Andrew Muir
Journal:  J Alcohol Drug Educ       Date:  2014-12

8.  Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users.

Authors:  Lauren E Cipriano; Gregory S Zaric; Mark Holodniy; Eran Bendavid; Douglas K Owens; Margaret L Brandeau
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

Review 9.  From Incarceration to Reintegration: Using the Human Services Model to Manage Canadian Prisoner Mental Health.

Authors:  Colin MacKenzie; Joanna Amirault
Journal:  J Correct Health Care       Date:  2021-03

10.  Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services.

Authors:  Shiela M Strauss; Janetta Astone-Twerell; Corrine E Munoz-Plaza; Don C Des Jarlais; Marya Gwadz; Holly Hagan; Andrew Osborne; Andrew Rosenblum
Journal:  BMC Health Serv Res       Date:  2007-03-08       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.